BETA


2023/0226(COD) Plants obtained by certain new genomic techniques and their food and feed

Progress: Awaiting Council's 1st reading position

RoleCommitteeRapporteurShadows
Lead ENVI POLFJÄRD Jessica (icon: EPP EPP) CLERGEAU Christophe (icon: S&D S&D), HUITEMA Jan (icon: Renew Renew), HÄUSLING Martin (icon: Verts/ALE Verts/ALE), FIOCCHI Pietro (icon: ECR ECR), SARDONE Silvia (icon: ID ID), HAZEKAMP Anja (icon: GUE/NGL GUE/NGL)
Committee Opinion AGRI VRECIONOVÁ Veronika (icon: ECR ECR) Michaela ŠOJDROVÁ (icon: PPE PPE), Juozas OLEKAS (icon: S&D S&D), Sandra PEREIRA (icon: GUE/NGL GUE/NGL), Benoît BITEAU (icon: Verts/ALE Verts/ALE), Elena LIZZI (icon: ID ID), Asger CHRISTENSEN (icon: RE RE)
Lead committee dossier:
Legal Basis:
RoP 57_o, TFEU 043, TFEU 114, TFEU 168-p4

Events

2024/04/24
   EP - Decision by Parliament, 1st reading
Details

The European Parliament adopted by 336 votes to 238, with 41 abstentions, a legislative resolution on the proposal for a regulation of the European Parliament and of the Council on plants obtained by certain new genomic techniques and their food and feed, and amending Regulation (EU) 2017/625.

The European Parliament’s position adopted at first reading under the ordinary legislative procedure amends the proposal as follows:

Subject matter

This proposed Regulation, in accordance with the precautionary principle lays down specific rules for the deliberate release into the environment for any other purpose than placing on the market of plants obtained by certain new genomic techniques (‘NGT plants’) and for the placing on the market of food and feed containing, consisting of or produced from such plants, and of products, other than food or feed, containing or consisting of such plants, ensuring a high level of protection of human and animal health and the environment.

Release

An NTG plant may only be deliberately released into the environment for purposes other than placing on the market, and an NTG product may only be placed on the market if:

- the plant is a category 1 NTG plant that has been the subject of a decision declaring this status;

- the plant is a category 2 NGT plant and has been granted consent or has been authorised.

The implementation, enforcement and application of this Regulation should not have the object or effect of preventing or impeding imports from third countries of NGT plants and products that meet the same standards as those laid down in this Regulation.

Ban on all patents filed for NGT plants

Members included a new article stating that NGT plants, plant material, parts thereof, genetic information and the process features they contain should not be patentable . They also request a report by June 2025 on the impact of patents on breeders' and farmers' access to varied plant reproductive material as well as a legislative proposal to update EU rules on intellectual property rights accordingly.

NGT 1 plants

A NGT plant is considered equivalent to conventional plants if certain conditions are met. Members, therefore, amend the rules concerning the size and number of modifications needed for a NGT plant to be considered equivalent to conventional plants. The Commission should establish and maintain a database listing the decisions declaring the category 1 NGT plant status. Members called for the database to be publicly available, and in an online format.

Seven years after the entry into force of this Regulation, the Commission should present a report on the evolution of the consumers' and producers' perception , accompanied, where appropriate, by a legislative proposal.

Labelling

According to Members, category 1 NGT plants should bear a label indicating the words ‘ New Genomic Techniques ’. In the case of plant reproductive material, it should be followed by the identification number of the NGT plant(s) it has been derived from.

Verification procedure of category 1 NGT plant status before undertaking a deliberate release for any other purpose than placing on the market

The person intending to undertake the deliberate release should submit a request which should contain information on:

- a description of the trait or traits and characteristics which have been introduced or modified, including information on the technique or techniques used to obtain the trait or the traits and including disclosure of the sequence of genetic modification;

- any patent or pending application for a patent that covers the whole or part of Cat.1 NGT plant.

The other Member States and the Commission may make reasoned objections to the verification report, as regards the fulfilment of the criteria set out in Annex I, within 20 days from the date of receipt of that report. In the absence of any reasoned scientific objections from a Member State or the Commission, within this deadline, the national competent authority that prepared the verification report should adopt a decision declaring whether the NGT plant is a category 1 NGT plant. The national competent authority should transmit the decision within 10 working days to the requester, the other Member States and the Commission.

In cases where a reasoned objection is made by another Member State or by the Commission, the competent authority that prepared the verification report should make the reasoned objections publicly available without undue delay.

If the monitoring results show that there is a risk to health or the environment, or if new scientific data supports this hypothesis, the competent authority may withdraw its decision declaring whether the NGT plant is a category 1 NGT plant.

Where a declaration of Category 1 NTG plant status has not yet been made, the person intending to place an NTG product on the market should submit an application for verification to the Authority, including the denomination of the variety and a monitoring plan for environmental effects.

Organic production

Category 2 NGT plants will be banned in organic production. However, it is necessary to clarify the status of category 1 NGT plants for the purposes of organic production. Currently, the compatibility of the use of new genomic techniques with the principles of organic production requires further consideration. The use of category 1 NGT plants should therefore be prohibited in organic production, until such further consideration takes place.

The amended text stipulated that the adventitious or technically unavoidable presence of category 1 NGT plants, reproductive material or parts thereof in organic production, or in non-organic products authorised in organic production in accordance with Regulation (EU) 2018/848, should not constitute non-compliance with that Regulation.

NGT 2 plants

For NGT 2 plants, Members agreed to maintain most of the requirements of the GMO legislation, which is among the strictest in the world, including the authorisation procedure.

In view of the precautionary principle, a monitoring plan for environmental effects should always be required when consent is first given. It should only be possible to waive the requirement for monitoring upon the renewal of consent, provided that it has been demonstrated that the category 2 NGT plant does not pose risks that need monitoring, such as indirect, delayed or unforeseen effects on human health or on the environment.

Documents
2024/04/17
   CofR - Committee of the Regions: opinion
Documents
2024/04/03
   FR_SENATE - Contribution
Documents
2024/02/07
   IT_CHAMBER - Contribution
Documents
2024/02/07
   EP - Results of vote in Parliament
2024/02/07
   EP - Decision by Parliament, 1st reading
Details

The European Parliament adopted by 307 votes to 263, with 41 abstentions, amendments on the proposal for a regulation of the European Parliament and of the Council on plants obtained by certain new genomic techniques and their food and feed, and amending Regulation (EU) 2017/625.

The matter was referred back to the committee responsible for inter-institutional negotiations.

Subject matter

This proposed regulation, in accordance with the precautionary principle, lays down specific rules for the deliberate release into the environment for any other purpose than placing on the market of plants obtained by certain new genomic techniques (‘NGT plants’) and for the placing on the market of food and feed containing, consisting of or produced from such plants, and of products, other than food or feed, containing or consisting of such plants, ensuring a high level of protection of human and animal health and the environment.

Release

An NTG plant may only be deliberately released into the environment for purposes other than placing on the market, and an NTG product may only be placed on the market if:

- the plant is a category 1 NTG plant that has been the subject of a decision declaring this status;

- the plant is a category 2 NGT plant, and has been granted consent or has been authorised.

Ban on all patents filed for NGT plants

Members included a new article stating that NGT plants, plant material, parts thereof, genetic information and the process features they contain should not be patentable . They also request a report by June 2025 on the impact of patents on breeders' and farmers' access to varied plant reproductive material as well as a legislative proposal to update EU rules on intellectual property rights accordingly.

NGT 1 plants

A NGT plant is considered equivalent to conventional plants if certain conditions are met. Members, therefore, amend the rules concerning the size and number of modifications needed for a NGT plant to be considered equivalent to conventional plants. The Commission should establish and maintain a database listing the decisions declaring the category 1 NGT plant status.

Members called for the database to be publicly available, and in an online format.

Seven years after the entry into force of this Regulation, the Commission should present a report on the evolution of the consumers' and producers' perception , accompanied, where appropriate, by a legislative proposal.

Labelling

According to Members, category 1 NGT plants should bear a label indicating the words ‘ New Genomic Techniques ’. In the case of plant reproductive material, it should be followed by the identification number of the NGT plant(s) it has been derived from.

Appropriate document-based traceability for NGTs should be provided by the transmission and holding of information that products contain or consist of NGT plants and product, and the unique codes for those NGTs, at each stage of their placing on the market.

Verification procedure of category 1 NGT plant status

To obtain the declaration of category 1 NGT plant status, before undertaking a deliberate release of a NGT plant for any other purpose than placing on the market, the person intending to undertake the deliberate release should submit a request to verify whether the criteria set out in Annex I at least one of the traits referred to in Annex III, Part 1, and the exclusion criteria in Annex III, Part 2, are met.

That request should contain information on:

- a description of the trait or traits and characteristics which have been introduced or modified, including information on the technique or techniques used to obtain the trait or the traits and including disclosure of the sequence of genetic modification;

- any patent or pending application for a patent that covers the whole or part of Cat.1 NGT plant.

The other Member States and the Commission may make reasoned objections to the verification report, as regards the fulfilment of the criteria set out in Annex I, within 20 days from the date of receipt of that report. In the absence of any reasoned scientific objections from a Member State or the Commission, within this deadline, the national competent authority that prepared the verification report should adopt a decision declaring whether the NGT plant is a category 1 NGT plant. The national competent authority should transmit the decision within 10 working days to the requester, the other Member States and the Commission.

In cases where a reasoned objection is made by another Member State or by the Commission, the competent authority that prepared the verification report should make the reasoned objections publicly available without undue delay.

If the monitoring results show that there is a risk to health or the environment, or if new scientific data supports this hypothesis, the competent authority may withdraw its decision declaring whether the NGT plant is a category 1 NGT plant.

Organic production

Category 2 NGT plants will be banned in organic production. However, it is necessary to clarify the status of category 1 NGT plants for the purposes of organic production.

Currently, the compatibility of the use of new genomic techniques with the principles of organic production requires further consideration. The use of category 1 NGT plants should therefore be prohibited in organic production , until such further consideration takes place.

The amended text stipulated that the adventitious or technically unavoidable presence of category 1 NGT plants, reproductive material or parts thereof in organic production, or in non-organic products authorised in organic production in accordance with Regulation (EU) 2018/848, should not constitute non-compliance with that Regulation.

NGT 2 plants

For NGT 2 plants, Members agreed to maintain most of the requirements of the GMO legislation, which is among the strictest in the world, including the authorisation procedure.

In view of the precautionary principle, a monitoring plan for environmental effects should always be required when consent is first given. It should only be possible to waive the requirement for monitoring upon the renewal of consent, provided that it has been demonstrated that the category 2 NGT plant does not pose risks that need monitoring, such as indirect, delayed or unforeseen effects on human health or on the environment.

Documents
2024/02/07
   EP - Matter referred back to the committee responsible
2024/02/06
   EP - Debate in Parliament
2024/01/29
   EP - Committee report tabled for plenary, 1st reading
Details

The Committee on the Environment, Public Health and Food Safety adopted the report by Jessica POLFJÄRD (EPP, SE) on the proposal for a regulation of the European Parliament and of the Council on plants obtained by certain new genomic techniques and their food and feed and amending Regulation (EU) 2017/625.

The committee responsible recommended that the European Parliament's position adopted at first reading under the ordinary legislative procedure should amend the proposal as follows:

Subject

The Regulation should establish, in accordance with the precautionary principle, specific rules applicable to the deliberate release into the environment, for any purpose other than placing on the market, of plants obtained through certain new genomic techniques ('NTG plants') and to the placing on the market of food and feed consisting of, containing or produced from such plants as well as products, other than food and feed, consisting of or containing such plants.

The Regulation should ensure a high level of protection of human and animal health and the environment.

Status of category 1 NGT plants

The Commission is empowered to adopt delegated acts amending the criteria of equivalence of NGT plants to conventional plants in order to adapt them to scientific and technological progress as regards the types and extent of modifications which can occur naturally or through

conventional breeding.

The amended text stated that the adventitious or technically unavoidable presence of category 1 NGT plants, reproductive material or parts thereof in organic production, or in nonorganic products authorised in organic production in accordance with Regulation (EU) 2018/848 on organic production and labelling of organic products, should not constitute non-compliance with that Regulation.

Deliberate release of NGT plants for any other purpose than placing on the market and placing on the market of NGT products

The implementation, enforcement and application of this Regulation should not have the object or effect of preventing or impeding imports from third countries of NGT plants and products that meet the same standards as those laid down in this Regulation.

Labelling

The amended text stated that plant reproductive material, including for breeding and scientific purposes that contains or consists of category 1 NGT plant or plants and is made available to third parties, whether in return for payment or free of charge, should bear a label and a reference to a variety register automatically transmitted to the EU common register indicating the words ‘cat 1 NGT’, followed by the identification number of the NGT plant or plants it has been derived from.

Exclusion from patentability

A new article has been included stipulating that NGT plants, plant material, parts thereof, genetic information and the process features they contain should not be patentable.

Ensuring science-based verification processes

The proposed regulation also introduces verification procedures for NGT 1 prior to the deliberate release of plants for this category.

The report noted that the verification process should be based on the scientifically approved criteria set out in the annex defining a category 1 plant and, where appropriate, in close consultation with the European Commission and the European Food Safety Authority.

It is stated that the other Member States and the Commission may make reasoned objections to the verification report, as regards the fulfilment of the criteria set out in Annex I, within 20 days from the date of receipt of that report.

Reporting

The implementation report should identify and address any issues regarding biodiversity and environmental, human and animal health, changes to agronomic practices as well as socio-economic and ethical issues that may have arisen with the application of this Regulation.

By June 2025, the Commission should submit a report on the role and impact of patents on breeders' and farmers' access to varied plant reproductive material, as well as on innovation and, in particular, on opportunities for SMEs.

Documents
2024/01/24
   EP - Vote in committee, 1st reading
2024/01/08
   EP - Committee opinion
Documents
2023/12/14
   IT_SENATE - Contribution
Documents
2023/12/04
   CZ_SENATE - Contribution
Documents
2023/11/27
   HR_PARLIAMENT - Contribution
Documents
2023/11/22
   DK_PARLIAMENT - Contribution
Documents
2023/11/20
   RO_SENATE - Contribution
Documents
2023/11/19
   EP - Amendments tabled in committee
Documents
2023/11/19
   EP - Amendments tabled in committee
Documents
2023/11/19
   EP - Amendments tabled in committee
Documents
2023/11/19
   EP - Amendments tabled in committee
Documents
2023/10/27
   PT_PARLIAMENT - Contribution
Documents
2023/10/25
   EP - Committee draft report
Documents
2023/10/25
   NL_SENATE - Contribution
Documents
2023/10/19
   EP - Committee referral announced in Parliament, 1st reading
2023/10/19
   EP - Referral to associated committees announced in Parliament
2023/08/28
   EP - POLFJÄRD Jessica (EPP) appointed as rapporteur in ENVI
2023/08/28
   EP - VRECIONOVÁ Veronika (ECR) appointed as rapporteur in AGRI
2023/07/06
   EC - Document attached to the procedure
2023/07/06
   EC - Document attached to the procedure
2023/07/06
   EC - Document attached to the procedure
2023/07/06
   EC - Document attached to the procedure
2023/07/05
   EC - Legislative proposal published
Details

PURPOSE: to establish a specific regulatory framework for new genomic techniques (NGT) plants and their products.

PROPOSED ACT: Regulation of the European Parliament and of the Council.

ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

BACKGROUND: New Genomic Techniques (NGTs) are innovative tools that can help increase the sustainability and resilience of food systems and support the goals of the European Green Deal and the Farm to Fork Strategy. They allow precise and efficient development of improved plant varieties that can be climate resilient, pest resistant, require less fertilisers and pesticides, or ensure higher yields.

Since the adoption of the EU's GMO legislation in 2001, and especially in the last decade, a variety of new genomic techniques (NGTs) have been developed based on advances in biotechnology.

NGTs constitute a diverse group of genomic techniques, and each of them can be used in various ways to achieve different results and products. They can result in organisms with modifications equivalent to what can be obtained by conventional breeding methods or in organisms with more complex modifications.

To have a better understanding of all these recent advances, the Council requested the Commission in November 2019 to provide a study on NGTs. The 2021 Commission study concluded that the current rules - mainly the existing GMO legislation - lag behind scientific and technological progress and do not sufficiently facilitate the development and placing on the market of innovative NGT products. The EU needs an adapted framework for safe NGT plants benefitting farmers, consumers, and the environment.

CONTENT: the Commission is proposing this draft regulation to establish a regulatory framework for NGT plants, and their products . It proposes different procedures for the placing on the market of NGT plants.

The main objectives of the proposal are:

- maintaining a high level of protection of health and the environment;

- steering developments towards contribution to sustainability goals in a wide range of plant species, especially for the agri-food system;

- creating an enabling environment for research and innovation, especially for SMEs.

This proposal only concerns plants produced by targeted mutagenesis and cisgenesis and their food and feed products. Targeted mutagenesis induces mutations in the genome without insertion of foreign genetic material (e.g., changes are made within the same plant species). Cisgenesis is an insertion of genetic material into a recipient organism from a donor that is sexually compatible with the recipient organism (e.g., changes are made between naturally compatible plants).

The proposal does not include plants obtained by NGTs that introduce genetic material from a non-crossable species ( transgenesis ). Such techniques remain subject to the existing GMO legislation.

More specifically, the proposal seeks to:

- establish two categories of plants obtained by NGTs. Both categories will be subject to different requirements to reach the market taking into account their different characteristics and risk profiles.

1. Category 1 NGT plants : NGT plants comparable to naturally occurring or conventional plants. The plants from the first category will need to be notified. Information on category 1 NGT plants would be provided through the labelling of seeds, in a public database and through the relevant catalogues on plant varieties.

2. Category 2 NGT plants : NGT plants with more complex modifications. The plants from the second category will go through the more extensive process of the GMO directive. They would be subject to risk assessment and authorisation before could be put on the market. They would be traced and labelled as GMOs , with the possibility of a voluntary label to indicate the purpose of the genetic modification. The risk assessment, detection method and monitoring requirements would be adapted to different risk profiles and regulatory incentives would be available for NGT plants featuring traits that can:

- contribute to sustainability goals;

- give incentives to steer the development of plants towards more sustainability;

- ensure transparency about all NGT plants on the EU market (for e.g., through labelling of seeds);

- offer robust monitoring of economic, environmental and social impacts of NGT products.

Budgetary implications

Overall, the proposal will be budget neutral. The costs of this proposal, estimated at EUR 2.434 million will be fully covered by redeployments within existing financial envelopes of the current MFF.

The budgetary implications are mainly related to additional tasks to be carried out by EFSA in terms of new scientific and administrative tasks as regards the adapted risk assessment, the verification procedure for certain NGT plants and pre-submission advice. The Commission proposes to reinforce the budgetary envelope of EFSA by EUR 2.334 million from the unallocated margin of Heading 2b, which will be compensated through a reduction of the Single Market Programme, whose objectives are directly linked to those of this initiative, resulting in an increase of the unallocated margin of Heading 1.

In addition, new IT tools and database are also needed to implement the legislation. An amount of EUR 100 000 is foreseen under the Single Market Programme to integrate the NGT plants/products in the already existing Food Innovation Platform (FIP) and E-Submission Food Chain (ESFC) system.

Documents

Activities

Votes

A9-0014/2024 – Jessica Polfjärd – Rejection – Am 109= 137= #

2024/02/07 Outcome: -: 413, +: 178, 0: 46
AT HR BG SK PL HU EL CY ?? IE FI LV LU LT MT BE EE SI PT DK SE NL CZ RO DE ES FR IT
Total
17
12
15
13
47
18
17
5
1
13
12
6
6
10
5
20
7
7
21
14
19
26
20
31
87
53
71
64
icon: Verts/ALE Verts/ALE
69

Austria Verts/ALE

3

Poland Verts/ALE

For (1)

1

Greece Verts/ALE

For (1)

1

Ireland Verts/ALE

2

Finland Verts/ALE

Abstain (1)

3

Luxembourg Verts/ALE

For (1)

1

Lithuania Verts/ALE

Abstain (1)

2

Belgium Verts/ALE

3

Portugal Verts/ALE

1

Denmark Verts/ALE

2

Sweden Verts/ALE

3

Netherlands Verts/ALE

3

Czechia Verts/ALE

3

Romania Verts/ALE

1

Spain Verts/ALE

3

Italy Verts/ALE

3
icon: The Left The Left
33

Greece The Left

2

Cyprus The Left

2

Ireland The Left

Abstain (1)

4

Belgium The Left

For (1)

1

Denmark The Left

1

Sweden The Left

For (1)

1

Netherlands The Left

For (1)

1

Czechia The Left

1
icon: NI NI
43

Croatia NI

Against (1)

2

NI

1

Latvia NI

1

Belgium NI

Against (1)

1

Czechia NI

For (1)

1
4

France NI

For (1)

3
icon: ECR ECR
62

Croatia ECR

1

Bulgaria ECR

For (1)

1

Slovakia ECR

Against (1)

1

Greece ECR

1

Finland ECR

2

Lithuania ECR

1

Sweden ECR

3

Netherlands ECR

4

Romania ECR

1

France ECR

Against (1)

1
icon: ID ID
50
3

Estonia ID

Against (1)

1

Denmark ID

Against (1)

1

Czechia ID

Against (1)

1
icon: Renew Renew
94

Austria Renew

Against (1)

1

Croatia Renew

Against (1)

1

Bulgaria Renew

2

Poland Renew

1

Hungary Renew

2

Greece Renew

Against (1)

1

Ireland Renew

2

Finland Renew

3

Latvia Renew

Against (1)

1

Luxembourg Renew

2

Lithuania Renew

Against (1)

1

Belgium Renew

3

Estonia Renew

3

Slovenia Renew

2

Sweden Renew

3

Italy Renew

Against (2)

2
icon: S&D S&D
130

Slovakia S&D

Abstain (1)

1
4

Greece S&D

Against (1)

1

Cyprus S&D

Against (1)

1

Finland S&D

1

Latvia S&D

Against (1)

1

Luxembourg S&D

Against (1)

1

Lithuania S&D

2

Belgium S&D

For (1)

Against (1)

2

Estonia S&D

2

Slovenia S&D

2

Czechia S&D

Against (1)

1
icon: PPE PPE
156

Slovakia PPE

For (1)

Abstain (1)

4

Hungary PPE

Abstain (1)

1

Cyprus PPE

2

Finland PPE

3

Latvia PPE

3

Luxembourg PPE

2

Malta PPE

Against (1)

1

Estonia PPE

Against (1)

1

Slovenia PPE

3

Denmark PPE

Against (1)

1

A9-0014/2024 – Jessica Polfjärd – Amendments by the committee responsible – separate vote – Am 68 #

2024/02/07 Outcome: +: 320, -: 291, 0: 24
ES IT RO FI NL EE CZ LT SE SI IE SK LV LU DK ?? BE BG EL MT HR CY PT AT FR HU PL DE
Total
52
64
30
12
26
7
20
10
19
7
13
13
6
6
14
1
20
15
17
4
12
5
21
17
70
18
48
88
icon: PPE PPE
156

Finland PPE

Against (1)

3

Estonia PPE

For (1)

1

Slovenia PPE

3

Slovakia PPE

Against (1)

4

Luxembourg PPE

2

Denmark PPE

For (1)

1

Malta PPE

For (1)

1

Cyprus PPE

For (1)

1

Hungary PPE

Against (1)

1
icon: Renew Renew
94

Italy Renew

2

Finland Renew

3

Estonia Renew

3

Lithuania Renew

1
3

Slovenia Renew

2

Ireland Renew

2

Latvia Renew

For (1)

1

Luxembourg Renew

2

Bulgaria Renew

2

Greece Renew

1

Croatia Renew

Against (1)

1

Austria Renew

For (1)

1

Hungary Renew

2

Poland Renew

1
icon: ECR ECR
61

Lithuania ECR

Against (1)

1

Slovakia ECR

For (1)

1

Bulgaria ECR

For (1)

1

Greece ECR

Against (1)

1

Croatia ECR

Against (1)

1

France ECR

Against (1)

1
icon: ID ID
49

Estonia ID

Against (1)

1

Czechia ID

Against (1)

1

Denmark ID

Against (1)

1

Austria ID

3
icon: NI NI
43

Czechia NI

Against (1)

1

Latvia NI

Against (1)

1

Belgium NI

For (1)

1

Croatia NI

Against (1)

Abstain (1)

2

France NI

For (1)

3
4
icon: The Left The Left
33

Netherlands The Left

Against (1)

1

Czechia The Left

Abstain (1)

1

Sweden The Left

Against (1)

1

Ireland The Left

For (1)

4

Denmark The Left

Against (1)

1

Belgium The Left

Against (1)

1

Greece The Left

2

Cyprus The Left

2
icon: Verts/ALE Verts/ALE
69

Spain Verts/ALE

3

Italy Verts/ALE

3

Romania Verts/ALE

Against (1)

1

Finland Verts/ALE

3

Netherlands Verts/ALE

3

Czechia Verts/ALE

3

Lithuania Verts/ALE

2

Sweden Verts/ALE

3

Ireland Verts/ALE

2

Luxembourg Verts/ALE

Against (1)

1

Denmark Verts/ALE

2

Belgium Verts/ALE

3

Greece Verts/ALE

Against (1)

1

Portugal Verts/ALE

Against (1)

1

Austria Verts/ALE

3

Poland Verts/ALE

Against (1)

1
icon: S&D S&D
130

Finland S&D

1

Estonia S&D

2

Czechia S&D

Against (1)

1

Lithuania S&D

2

Slovenia S&D

2

Slovakia S&D

Against (1)

1

Latvia S&D

Against (1)

1

Luxembourg S&D

Against (1)

1

Belgium S&D

2

Greece S&D

Against (1)

1

Malta S&D

3

Cyprus S&D

2

A9-0014/2024 – Jessica Polfjärd – Amendments by the committee responsible – separate vote – Am 84 #

2024/02/07 Outcome: -: 333, +: 268, 0: 35
PL HU FR DE BE MT AT BG CY HR EL SK ?? NL LV LU SI IE FI EE LT DK RO PT SE CZ IT ES
Total
48
18
70
87
20
5
17
15
6
12
17
13
1
26
6
6
7
13
12
7
10
14
29
21
19
20
64
53
icon: Verts/ALE Verts/ALE
69

Poland Verts/ALE

For (1)

1

Belgium Verts/ALE

3

Austria Verts/ALE

3

Greece Verts/ALE

For (1)

1

Netherlands Verts/ALE

3

Luxembourg Verts/ALE

For (1)

1

Ireland Verts/ALE

2

Finland Verts/ALE

3

Lithuania Verts/ALE

2

Denmark Verts/ALE

2

Romania Verts/ALE

1

Portugal Verts/ALE

1

Sweden Verts/ALE

3

Czechia Verts/ALE

3

Italy Verts/ALE

3

Spain Verts/ALE

3
icon: S&D S&D
131

Belgium S&D

2

Cyprus S&D

2

Croatia S&D

4

Greece S&D

1

Slovakia S&D

For (1)

1

Latvia S&D

For (1)

1

Luxembourg S&D

For (1)

1

Slovenia S&D

2

Finland S&D

Against (1)

1

Estonia S&D

2

Lithuania S&D

2

Czechia S&D

Against (1)

1
icon: The Left The Left
33

Belgium The Left

For (1)

1

Cyprus The Left

2

Greece The Left

2

Netherlands The Left

For (1)

1

Ireland The Left

Abstain (1)

4

Denmark The Left

1

Portugal The Left

4

Sweden The Left

For (1)

1

Czechia The Left

Against (1)

1
icon: NI NI
42

France NI

For (1)

3
4

Belgium NI

For (1)

1

Croatia NI

2

NI

1

Latvia NI

1

Czechia NI

Against (1)

1
icon: ECR ECR
61

France ECR

Abstain (1)

1

Bulgaria ECR

Against (1)

1

Croatia ECR

1

Greece ECR

1

Slovakia ECR

Against (1)

1

Netherlands ECR

4

Finland ECR

2

Lithuania ECR

Against (1)

1

Sweden ECR

3
icon: ID ID
50

Austria ID

3

Estonia ID

Against (1)

1

Denmark ID

Against (1)

1

Czechia ID

Against (1)

1
icon: Renew Renew
92

Poland Renew

1

Hungary Renew

2

Belgium Renew

3

Austria Renew

Against (1)

1

Bulgaria Renew

2

Croatia Renew

For (1)

1

Greece Renew

Against (1)

1

Slovakia Renew

3

Latvia Renew

Against (1)

1

Luxembourg Renew

2

Slovenia Renew

Against (1)

Abstain (1)

2

Ireland Renew

2

Finland Renew

3

Estonia Renew

For (1)

Against (2)

3

Lithuania Renew

Against (1)

1

Sweden Renew

3

Italy Renew

Against (2)

2
icon: PPE PPE
158

Hungary PPE

Abstain (1)

1

Malta PPE

Against (1)

1

Cyprus PPE

2

Slovakia PPE

4

Latvia PPE

3

Luxembourg PPE

2

Slovenia PPE

3

Finland PPE

3

Estonia PPE

Against (1)

1

Denmark PPE

Against (1)

1

A9-0014/2024 – Jessica Polfjärd – Article 1, § 1 – Am 244 #

2024/02/07 Outcome: -: 313, +: 221, 0: 92
HU FR HR ES AT DE BE CY SK SI EL ?? MT LU IE LV BG NL LT FI PT EE RO DK SE PL CZ IT
Total
18
70
11
52
17
87
20
6
12
6
17
1
4
6
13
6
15
26
10
12
20
7
28
14
19
45
20
64
icon: Verts/ALE Verts/ALE
69

Spain Verts/ALE

3

Austria Verts/ALE

3

Belgium Verts/ALE

3

Greece Verts/ALE

For (1)

1

Luxembourg Verts/ALE

For (1)

1

Ireland Verts/ALE

2

Netherlands Verts/ALE

3

Lithuania Verts/ALE

2

Finland Verts/ALE

For (1)

Against (1)

Abstain (1)

3

Portugal Verts/ALE

1

Romania Verts/ALE

1

Denmark Verts/ALE

2

Sweden Verts/ALE

3

Poland Verts/ALE

For (1)

1

Czechia Verts/ALE

3

Italy Verts/ALE

3
icon: S&D S&D
130
4

Belgium S&D

2

Cyprus S&D

For (1)

Abstain (1)

2

Slovakia S&D

Abstain (1)

1

Slovenia S&D

2

Greece S&D

Abstain (1)

1

Malta S&D

3

Luxembourg S&D

For (1)

1

Latvia S&D

Against (1)

1

Lithuania S&D

2

Finland S&D

Against (1)

1

Estonia S&D

2

Czechia S&D

Against (1)

1
icon: The Left The Left
33

Belgium The Left

For (1)

1

Cyprus The Left

2

Greece The Left

2

Ireland The Left

Abstain (1)

4

Netherlands The Left

For (1)

1

Denmark The Left

1

Sweden The Left

For (1)

1

Czechia The Left

Against (1)

1
icon: NI NI
42

France NI

For (1)

3

Croatia NI

Abstain (1)

2
4

Belgium NI

For (1)

1

Slovakia NI

For (1)

3

NI

1

Latvia NI

1

Czechia NI

For (1)

1
icon: ID ID
49

Austria ID

3

Estonia ID

Against (1)

1

Denmark ID

Against (1)

1

Czechia ID

Against (1)

1
icon: ECR ECR
58

France ECR

Abstain (1)

1

Croatia ECR

Abstain (1)

1

Slovakia ECR

Against (1)

1

Greece ECR

1

Bulgaria ECR

Against (1)

1

Netherlands ECR

Abstain (1)

4

Lithuania ECR

Abstain (1)

1

Finland ECR

2

Sweden ECR

3
icon: Renew Renew
93

Hungary Renew

2

Croatia Renew

Abstain (1)

1

Austria Renew

Against (1)

1

Belgium Renew

3

Slovenia Renew

2

Greece Renew

Against (1)

1

Luxembourg Renew

2

Ireland Renew

2

Latvia Renew

Against (1)

1

Bulgaria Renew

2

Lithuania Renew

Against (1)

1

Finland Renew

3

Estonia Renew

3

Sweden Renew

3

Poland Renew

1

Italy Renew

Against (2)

2
icon: PPE PPE
152

Hungary PPE

1

Cyprus PPE

2

Slovakia PPE

Abstain (1)

4

Slovenia PPE

2

Malta PPE

Against (1)

1

Luxembourg PPE

2

Latvia PPE

3

Finland PPE

3

Estonia PPE

Against (1)

1

Denmark PPE

Against (1)

1

A9-0014/2024 – Jessica Polfjärd – Article 2, § 1, point 1 – Am 245 #

2024/02/07 Outcome: -: 335, +: 226, 0: 72
HU PL FR HR AT SK BE CY DE ?? MT EL LU IE NL SI LT LV BG FI EE PT DK SE CZ RO ES IT
Total
18
47
70
12
17
13
20
6
88
1
5
17
6
13
26
7
10
6
14
11
7
21
14
19
20
29
52
64
icon: Verts/ALE Verts/ALE
68

Poland Verts/ALE

For (1)

1

Austria Verts/ALE

3

Belgium Verts/ALE

3

Greece Verts/ALE

For (1)

1

Luxembourg Verts/ALE

For (1)

1

Ireland Verts/ALE

2

Netherlands Verts/ALE

3

Lithuania Verts/ALE

2

Finland Verts/ALE

For (1)

Against (1)

2

Portugal Verts/ALE

1

Denmark Verts/ALE

2

Sweden Verts/ALE

3

Czechia Verts/ALE

3

Romania Verts/ALE

1

Spain Verts/ALE

3

Italy Verts/ALE

3
icon: The Left The Left
33

Belgium The Left

For (1)

1

Cyprus The Left

2

Greece The Left

2

Ireland The Left

Abstain (1)

4

Netherlands The Left

For (1)

1

Denmark The Left

1

Sweden The Left

For (1)

1

Czechia The Left

Abstain (1)

1
icon: NI NI
43

France NI

For (1)

3

Croatia NI

Abstain (1)

2

Belgium NI

For (1)

1
4

NI

1

Latvia NI

1

Czechia NI

For (1)

1
icon: S&D S&D
131
4

Slovakia S&D

Abstain (1)

1

Belgium S&D

2

Cyprus S&D

For (1)

Abstain (1)

2

Greece S&D

Abstain (1)

1

Luxembourg S&D

For (1)

1

Slovenia S&D

2

Lithuania S&D

2

Latvia S&D

Against (1)

1

Finland S&D

Against (1)

1

Estonia S&D

2

Czechia S&D

Against (1)

1
icon: ECR ECR
60

France ECR

Abstain (1)

1

Croatia ECR

1

Slovakia ECR

Against (1)

1

Greece ECR

1

Netherlands ECR

Abstain (1)

4

Lithuania ECR

1

Bulgaria ECR

Against (1)

1

Finland ECR

2

Sweden ECR

3
icon: ID ID
49

Austria ID

3

Estonia ID

Against (1)

1

Denmark ID

Against (1)

1

Czechia ID

Against (1)

1
icon: Renew Renew
93

Hungary Renew

2

Poland Renew

1

Croatia Renew

Abstain (1)

1

Austria Renew

Against (1)

1

Belgium Renew

3

Greece Renew

Against (1)

1

Luxembourg Renew

2

Ireland Renew

2

Slovenia Renew

For (1)

Against (1)

2

Lithuania Renew

Against (1)

1

Latvia Renew

Against (1)

1

Bulgaria Renew

2

Finland Renew

3

Estonia Renew

3

Sweden Renew

3

Italy Renew

Against (2)

2
icon: PPE PPE
156

Hungary PPE

1

Slovakia PPE

Abstain (1)

4

Cyprus PPE

2

Malta PPE

Against (1)

1

Luxembourg PPE

2

Slovenia PPE

3

Latvia PPE

3

Finland PPE

3

Estonia PPE

Against (1)

1

Denmark PPE

Against (1)

1

A9-0014/2024 – Jessica Polfjärd – Article 2, after § 1 – Am 94= 246= #

2024/02/07 Outcome: -: 326, +: 277, 0: 32
PL HU FR AT HR BE DE SK MT EL CY SI BG ?? LV LU IE NL LT FI PT EE DK SE CZ RO IT ES
Total
48
18
70
17
11
20
88
13
5
17
6
7
15
1
6
6
13
26
10
12
21
7
13
19
20
29
65
52
icon: Verts/ALE Verts/ALE
68

Poland Verts/ALE

For (1)

1

Austria Verts/ALE

3

Belgium Verts/ALE

3